Diagnostic and Prognostic Value of Serum Vitronectin and Galectin-3 levels in Thyroid Tumors
Molecular Oncologic Imaging · 2025
DOI: 10.71286/moi.1600588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncologic Imaging, 2025. Verfasst von Esra Arslan und 6 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Objective
Increased expression of Galectin-3(Gal-3) and Vitronectin (VN) molecules has been the subject of research, since it may be a biological marker that can be used for the separation of benign and malignant tissues. We aimed to evaluate serum Gal-3 and VN expression levels in the presence of thyroid tissue, and evaluate the predictive and prognostic value of these molecules in the differential diagnosis of malignant tissues. Materials and Methods: 44 patients with thyroid nodules were included in this prospective study. Benign and malignant lesions were distinguished from thyroidectomy materials.
Results
Mean preoperative Gal-3 and VN values measured in malignant lesions were statistically significantly higher than preoperative Gal-3 and VN values in benign lesions (p-values: 0.007 and 0.009, respectively). Also, mean Gal-3 and VN values measured in serum were significantly reduced after operation compared to preoperative values (p-values
Zitieren
APA
Arslan, E., Alçın, G., Orhan, B., Sönmez, D., Trabulus, F. C., Sünter, A. V., & Ulusan, K. (2025). Diagnostic and Prognostic Value of Serum Vitronectin and Galectin-3 levels in Thyroid Tumors. Molecular Oncologic Imaging. https://doi.org/10.71286/moi.1600588
Vancouver
Arslan E, Alçın G, Orhan B, Sönmez D, Trabulus FC, Sünter AV, et al. Diagnostic and Prognostic Value of Serum Vitronectin and Galectin-3 levels in Thyroid Tumors. Molecular Oncologic Imaging. 2025. doi:10.71286/moi.1600588
BibTeX
@article{Arslan2025,
author = {Arslan, Esra and Alçın, Göksel and Orhan, Bağnu and Sönmez, Derya and Trabulus, F.didem Can and Sünter, Ahmet Volkan and Ulusan, Kıvılcım},
title = {Diagnostic and Prognostic Value of Serum Vitronectin and Galectin-3 levels in Thyroid Tumors},
journal = {Molecular Oncologic Imaging},
year = {2025},
doi = {10.71286/moi.1600588}
}
EUVIMED